BridgeBio have demonstrably boosted the development of a innovative treatment for cardiac amyloidosis, leveraging the compound. Initial patient information indicates potential outcomes for those suffering by this severe condition. The focus underscores BridgeBio's focus to addressing significant patient demands in the cardiology field. Attruby: Br